Wall Street is drawing fresh lines across the large-cap biopharma landscape, initiating coverage on two stocks and maintaining an overweight rating on another.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

They may appeal to different kinds of investors.

Amgen Inc. has reached a significant milestone as its stock hit an all-time high of 385.63 USD, with shares currently trading at $386.08, just shy of the 52-week high of $385.12.

Amgen Inc. (NASDAQ:AMGN) is one of the 10 best stocks to invest in during a recession. On February 27, 2026, Amgen Inc.

Buying $100 In AMGN: If an investor had bought $100 of AMGN stock 15 years ago, it would be worth $739.18 today based on a price of $379.40 for AMGN at the time of writing.

Last Friday, all three Wall Street benchmark stock indexes registered weekly losses. The Dow Jones Industrial Average fell ...

Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (NASDAQ: AMGN) started the year strong, ...

On Tuesday, Amgen (NASDAQ: AMGN) stock hit its one-year high, on continued momentum from a far better-than-expected quarterly earnings report. The immediate catalyst was a post-earnings price target ...

On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy ...